EMA heads urges greater transparency for clinical drug trials

10/22/2013 | MedCityNews.com

Guido Rasi, executive director of the European Medicines Agency, says that the release of clinical trial data would increase efficiency and cost-effectiveness in drug development, becoming a boon to drug companies rather than creating the loss of competitive advantage they fear. His article, with EMA co-authors, appears in the New England Journal of Medicine. AbbVie and InterMune have filed lawsuits to prevent such data releases.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA